$AMRZ

Amrize names Samuel Poletti as chief financial officer

Amrize (NYSE:AMRZ) appointed Samuel J. Poletti as CFO, replacing Baris Oran. Poletti previously led Amrize's spin-off from Holcim. The company also named Dillon Cumming as VP of Investor Relations. Amrize reported $11.8B revenue in 2025 and operates 1,000 sites with 19,000 employees.

Original reporting
Published Aug 24, 2026, 9:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 6:41 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$AMRZ
Neutral
medium confidence
Mentioned
$AMRZ
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$AMRZNeutralMed
01

Why it matters

The CFO appointment provides fresh leadership but does not constitute a material corporate event.

02

Market read

Executive change news with moderate relevance for traders monitoring Amrize.

03

What to watch

Potential integration challenges from the recent spin‑off and broader market volatility.

Relevance 7/10Novelty 7/10Timing: effective today

Background

Amrize (NYSE:AMRZ) recently spun off from Holcim and operates over 1,000 sites in the U.S. and Canada.

Company-level read

Ticker impact

$AMRZNeutralMedium confidence
Context

Amrize announced the appointment of Samuel J. Poletti as its new Chief Financial Officer effective today.

Expected impact

Potential modest upside if market views the appointment positively.

Evidence & confidence

New CFO with extensive M&A experience could improve execution, but impact is uncertain.

Market effects

May signal stronger financial leadership for the building materials sector.

Limited to North American investors focused on Amrize.

Low

Counterpoint

The appointment may not translate into operational improvements, keeping the stock flat.

Key entities

  • Samuel J. Poletti

    New Chief Financial Officer of Amrize

  • Jan Jenisch

    Chairman and CEO of Amrize

Related articles

$AMRZMedAI 8/10

Amrize (AMRZ) Q2 2026 Earnings Call Transcript

Amrize AG (AMRZ) reported Q2 2026 revenue of $3.49B, up 8.6%, and net income of $476M, up 14.4%, with adjusted EBITDA of $986M. Management raised fiscal 2026 revenue guidance to $12.5B-$12.7B but revised adjusted EBITDA to $3.1B-$3.2B due to oil-driven cost inflation. The company cited data center and infrastructure demand.

$AMRZMedAI 8/10

Amrize Q2 EPS misses $0.94 estimate as costs weigh on margins

Amrize (NYSE: AMRZ) reported Q2 2026 adjusted EPS of $0.88, below the $0.94 consensus estimate. Revenue rose 8.51% to $3.494 billion, beating the $3.365 billion expectation. Net income increased 14.4% to $476 million. The company raised FY2026 revenue guidance to $12.5B-$12.7B but lowered adjusted EBITDA guidance to $3.1B-$3.2B due to cost inflation.

$AMRZMed

RBC Downgrades Amrize After A Rare Q2 Miss

RBC downgraded Amrize after a rare Q2 miss and reduced guidance, citing a timing mismatch between input-cost increases and the full pass-through of surcharges and price hikes. RBC cut 2026-2028 EBITDA estimates by 4%, 6%, and 7% and EPS by 12%, 14%, and 15%, lowering its stock rating to underperform and price target to $48 from $60.